Exagen Inc.

Healthcare

NASDAQ:XGN · NASDAQ Global Market

Market Cap $101.23M Beta 2.02 P/E (TTM) -5.5

$4.67 +4.24%

+$0.19 today

52W Low $2.59High $12.23

Vol 0.14M · Avg 0.40M

EPS (TTM)-$0.85

Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-34.41%

Period High

$11.96

Period Low

$2.65

Latest

$4.67

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

BioAge Labs, Inc.

NASDAQ:BIOA

$679.20M

Aclaris Therapeutics, Inc.

NASDAQ:ACRS

$520.97M

Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

$353.00M

NeoGenomics, Inc.

NASDAQ:NEO

$290.37M

Sight Sciences, Inc.

NASDAQ:SGHT

$279.12M

Alpha Teknova, Inc.

NASDAQ:TKNO

$225.18M

Lifecore Biomedical, Inc.

NASDAQ:LFCR

$211.55M

Sanara MedTech Inc.

NASDAQ:SMTI

$190.70M

Stereotaxis, Inc.

AMEX:STXS

$179.84M

MDxHealth S.A.

MDXH

$27.85M

What is the latest XGN filing?

The latest filing shown is 8-K dated Jun 9, 2026.

How many recent filings does XGN have?

Intrinsic Alpha currently shows 20 recent filings for XGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.